Jeffrey S. Cohen
Managing Director, Equity Research
Mr. Cohen is responsible for equity research coverage of medical technology and healthcare services. He has 19 years of experience directly involved in the worldwide financial markets, of which he has spent the past 11 years directly involved with healthcare research and sales. Prior to joining Ladenburg Thalmann, he was a Senior Healthcare Research Analyst at C.K. Cooper & Company focusing upon the biotechnology, medical technology, and healthcare services segments. Mr. Cohen also served as a healthcare research analyst at Jesup & Lamont Inc., where he focused upon medical technology with sector specialization within Cardiology, Vascular, Orthopedics and Diabetes. Prior to equity research & sales, he spent seven years trading and managing fixed‐income and equity derivative products at Cantor Fitzgerald, Sanwa Securities and the American Stock Exchange. Mr. Cohen holds a B.S.E. in Systems Engineering from the University of Pennsylvania and an M.B.A. from the University of Miami. He has also served as an Adjunct Professor of Business & Management at Lynn University teaching Economics, Management, and International Business.